Evidence map›Paper›PMID 39125710›Full record

ArticleInternational journal of molecular sciences2024

Personalized Assessment for Cancer Prevention, Detection, and Treatment.

Laura Paleari

Registry-linked trialAbstract readEditorial
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07592962 (Whole-life Investigation of Lishui Longevity Cohort Study), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07592962 recruitingnot on this mapstarted 2026, after this paper: background citation

Whole-life Investigation of Lishui Longevity Cohort Study

Typeobservational_patient_registrySponsorThe Fifth Affiliated Hospital of Wenzhou Medical University & Lishui Central HospitalRan2026 to 2036Enrolled4,500ConditionsIschemic Stroke, Chronic Disease, Cardiovascular
3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Laura PaleariResearch, Innovation and HTA Unit, Liguria Health Authority, A.Li.Sa., 16121 Genova, Italy.ORCID 0000-0002-6176-2979

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The intention of this Special Issue is to highlight research that aims to recognize cancer's complexity to better prevent or treat its occurrence [...].

Indexed as

NeoplasmsPrecision MedicineBiomarkers, TumorEarly Detection of CancerHumansBiomarkers, Tumor

Identifiers

PMID39125710
PMCPMC11311957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.